Get started
Markets US Stocks Health Technology Pharmaceuticals: Major

Opiant Pharmaceuticals, Inc OPNT

OPNT NASDAQ
OPNT
Opiant Pharmaceuticals, Inc NASDAQ
See more on advanced chartSee more on advanced chart
 
No trades
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
See more on advanced chartSee more on advanced chart
Overview
News Ideas Financials Technicals

OPNT Chart

Trade OPNT with trusted brokers on TradingView Open account

Ideas

OPNT Bullish
OPNT
, 1DLong
OPNT: OPNT Bullish

Yesterday's candle tested two fibonacci levels and closed just under the 20ema just 2 days after bouncing off support at $10.50. The MACD is curling up and I feel this micro float stock could have an explosive move to the upside. First target $14.03

OPNT Long
OPNT
, 1DLong
OPNT: OPNT Long

Entry signals on chart

OPNT breaking out
OPNT
, 1DLong
OPNT: OPNT breaking out

Very dynamic stock with low float. Looks like its respecting the longer term up trend on the weekly. Accumulating and selling on the next big opiate news is the plan. Looking for a gap fill to $24 and then to $40ish.

OPNT bollinger snap
OPNT
, DLong
OPNT: OPNT bollinger snap

bollinger bounce and rsi bounce

OPNT EW
OPNT
, DLong
OPNT: OPNT EW

Elliot wave idea in the middle of a wave 3 gain.

Technicals

Analyst rating

Financials

Valuation
Enterprise Value/EBITDA, TTM —
Enterprise Value, FQ —
Market Cap — Basic —
Number of Employees —
Number of Shareholders —
Price/Earnings, TTM —
Price/Revenue, TTM —
Price/Book Ratio, FY —
Price/Sales Ratio, FY —
Balance Sheet
Current Ratio, FQ —
Debt to Equity, FQ —
Net Debt, FQ —
Quick Ratio, FQ —
Total Assets, FQ —
Total Debt, FQ —
Operating Metrics
Return on Assets, TTM —
Return on Equity, TTM —
Return on Invested Capital, TTM —
Revenue per Employee, TTM —
Price History
Average Volume (10 day) —
Beta - 1 Year —
Price - 52 Week High —
Price - 52 Week Low —
Dividends
Dividends Paid, FY —
Dividends per Share, FY —
Expected Annual Dividends —
Dividends Yield —
Margins
Net Margin, TTM —
Gross Margin, TTM —
Operating Margin, TTM —
Pretax Margin, TTM —
Income Statement
Basic EPS, Net Income —
Earnings per Share, Basic, TTM —
EBITDA, TTM —
Gross Profit, FY —
Last Annual EPS —
Last Annual Revenue, FY —
Net Income, FY —
Total Revenue, FY —
Free Cash Flow, TTM —
More financials

Profile

Sector: Health Technology
Industry: Pharmaceuticals: Major
Opiant Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the development of pharmaceutical solutions for common addictions and related disorders. The firm focuses on developing treatment to reverse opioid overdoses, treatment for overweight and obese patients with binge eating disorder and treatment for patients with Bulimia Nervosa. Its principal product Naloxone is a medicine which is available through injection can reverse the overdose of prescription and illicit opioids. The company was founded on June 21, 2005 and is headquartered in Santa Monica, CA.

Breaking news

More news